| Crossroads Care Center | |
| 965 Mcmillan Street, Worthington, Minnesota 56187 | |
| (507) 376-5312 | |
| Name | Crossroads Care Center |
|---|---|
| Location | 965 Mcmillan Street, Worthington, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 67.8% |
| Medicare ID (CCN) | 245395 |
| Legal Business Name | Crossroads Worthington Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1154943975 |
| Organization Name | NOBLES CROSSROADS HOLDINGS LLC |
| Address | 965 Mcmillan St, Worthington, MN 56187 |
| Phone Number | 507-376-5312 |
News Archive
African countries should focus on preventing diarrhea - the biggest killer of children in Africa - in order to achieve Millennium Development Goal targets, Yunia Musaazi, WaterAid's East Africa policy advisor, told delegates at the 15th African Union Summit, PANA/Afrique en ligne reports.
Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., of the Kashiwaba Neurosurgical Hospital in Sapporo, Japan has treated the first patient in Japan with alternating electric field therapy.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
The Canadian Diabetes Association is urging candidates who are seeking office in the 2010 New Brunswick Provincial Election to take diabetes seriously by committing to a list of priorities that will help improve the lives of New Brunswickers who live with diabetes.
Movie villains from Norman Bates to Hannibal Lecter have popularized the notion of the psychopath as cold, cruel, lacking in empathy and beyond the reach of treatment.
› Verified 6 days ago
| NPI Number | 1215961768 |
| Organization Name | ATCHISON ENTERPRISES INCORPORATED |
| Doing Business As | CROSSROADS CARE CENTER |
| Address | 965 Mcmillan St, Worthington, MN 56187 |
| Phone Number | 507-376-5312 |
News Archive
African countries should focus on preventing diarrhea - the biggest killer of children in Africa - in order to achieve Millennium Development Goal targets, Yunia Musaazi, WaterAid's East Africa policy advisor, told delegates at the 15th African Union Summit, PANA/Afrique en ligne reports.
Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., of the Kashiwaba Neurosurgical Hospital in Sapporo, Japan has treated the first patient in Japan with alternating electric field therapy.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
The Canadian Diabetes Association is urging candidates who are seeking office in the 2010 New Brunswick Provincial Election to take diabetes seriously by committing to a list of priorities that will help improve the lives of New Brunswickers who live with diabetes.
Movie villains from Norman Bates to Hannibal Lecter have popularized the notion of the psychopath as cold, cruel, lacking in empathy and beyond the reach of treatment.
› Verified 6 days ago
| NPI Number | 1679934350 |
| Organization Name | CROSSROADS WORTHINGTON OPERATIONS, LLC |
| Doing Business As | CROSSROADS CARE CENTER |
| Address | 965 Mcmillan St, Worthington, MN 56187 |
| Phone Number | 507-376-5312 |
News Archive
African countries should focus on preventing diarrhea - the biggest killer of children in Africa - in order to achieve Millennium Development Goal targets, Yunia Musaazi, WaterAid's East Africa policy advisor, told delegates at the 15th African Union Summit, PANA/Afrique en ligne reports.
Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., of the Kashiwaba Neurosurgical Hospital in Sapporo, Japan has treated the first patient in Japan with alternating electric field therapy.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
The Canadian Diabetes Association is urging candidates who are seeking office in the 2010 New Brunswick Provincial Election to take diabetes seriously by committing to a list of priorities that will help improve the lives of New Brunswickers who live with diabetes.
Movie villains from Norman Bates to Hannibal Lecter have popularized the notion of the psychopath as cold, cruel, lacking in empathy and beyond the reach of treatment.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
African countries should focus on preventing diarrhea - the biggest killer of children in Africa - in order to achieve Millennium Development Goal targets, Yunia Musaazi, WaterAid's East Africa policy advisor, told delegates at the 15th African Union Summit, PANA/Afrique en ligne reports.
Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., of the Kashiwaba Neurosurgical Hospital in Sapporo, Japan has treated the first patient in Japan with alternating electric field therapy.
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,386,027, "Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery," for the Prelude SkinPrep System, the skin permeation component of the Symphony CGM System.
The Canadian Diabetes Association is urging candidates who are seeking office in the 2010 New Brunswick Provincial Election to take diabetes seriously by committing to a list of priorities that will help improve the lives of New Brunswickers who live with diabetes.
Movie villains from Norman Bates to Hannibal Lecter have popularized the notion of the psychopath as cold, cruel, lacking in empathy and beyond the reach of treatment.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $32858 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 28.26 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.19 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 38.46 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 29.36 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.69 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.31 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 38.68 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.59 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 45.22 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 36.63 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.87 | 95.98 |